Abstract Minimal residual disease (MRD) in acute myelogenous leukemia (AML) is emerging as an independent risk factor for disease relapse and has significant potential to guide therapeutic decisions. However, current methods for detecting gene mutation-based MRD are limited by a lack
Abstract Targeted next-generation sequencing has become a critical tool for the interrogation of genomic events in myeloid malignancies. In this webinar, Dr. Eric Padron of the Moffitt Cancer Center, discussed his experience using the RainDance ThunderBolts Myeloid panel focusing on h
Abstract The RainDrop® Digital PCR System is the industry’s most sensitive instrument for researching nucleic acid detection and disease monitoring. Capable of producing up to 10 million picoliter sized droplets, the RainDrop Digital PCR System surpasses all existing technologies and
Abstract RainDance Technologies’ ThunderBolts™ Cancer Panel is a comprehensive next-generation DNA sequencing (NGS) solution. Our solution enables researchers to profile somatic mutations in a wide range of tumor samples in Superior coverage: 100% at ≥100x coverage depth for samples w
Abstract The RainDrop® Digital PCR System is a highly sensitive tool for precise quantification of nucleic acids using standard probe-based qPCR reagents. The system features an unprecedented multiplexing capability made possible by RainDance’s proprietary digital droplet technology p
Want more information? Get in touch with our team to learn more about our products. Abstract RainDance Technologies’ RainDrop™ Digital PCR System has many unique advantages for working with RNA. With a simple single pipetting step into a well on a disposable chip, the RainDrop System
Abstract Digital PCR is poised to make a significant impact on disease research and the development of molecular diagnostics. Its ability to precisely analyze nucleic acids at a molecular level makes it ideal for tasks such as detecting copy number variation and point mutations. In th
RainDance Technologies is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.